Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vytorin versus high-dose atorvastatin in high-risk hypercholesterolaemia
ACTRN12606000374561Phase 4Recruiting
- Sponsor
- Merck & Co.
- Start
- Sep 2006
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypercholesterolemia comparing Vytorin arm with Atorvastatin 80 mg arm (2 arms). Primary endpoint: Change in low-density lipoprotein cholesterol concentration. Started Sep 2006; status: recruiting.
02
Drugs
Vytorinatorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on ACTRN12606000374561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000374561.